ASMB Assembly Biosciences, Inc.

+0.05  (0%)
Previous Close 25.35
Open 25.32
Price To book 6.47
Market Cap 440.59M
Shares 17,346,000
Volume 21,320
Short Ratio 4.55
Av. Daily Volume 57,202

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data from second trial did not meet primary endpoint - Feb 2014. Will not pursue future development
VEN 307 (diltiazem cream)
Anal fissures